Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
We report a group of patients presenting with a progressive dementia syndrome characterized by predominant dysfunction in core executive functions, relatively young age of onset and positive biomarkers for Alzheimer’s pathophysiology. Atypical frontal, dysexecutive/behavioural variants and early-onset variants of Alzheimer’s disease have been previously reported, but no diagnostic criteria exist for a progressive dysexecutive syndrome. In this retrospective review, we report on 55 participants diagnosed with a clinically defined progressive dysexecutive syndrome with 18F-fluorodeoxyglucose-positron emission tomography and Alzheimer’s disease biomarkers available. Sixty-two per cent of participants were female with a mean of 15.2 years of education. The mean age of reported symptom onset was 53.8 years while the mean age at diagnosis was 57.2 years. Participants and informants commonly referred to initial cognitive symptoms as ‘memory problems’ but upon further inquiry described problems with core executive functions of working memory, cognitive flexibility and cognitive inhibitory control. Multi-domain cognitive impairment was evident in neuropsychological testing with executive dysfunction most consistently affected. The frontal and parietal regions which overlap with working memory networks consistently demonstrated hypometabolism on positron emission tomography. Genetic testing for autosomal dominant genes was negative in all eight participants tested and at least one APOE ε4 allele was present in 14/26 participants tested. EEG was abnormal in 14/17 cases with 13 described as diffuse slowing. Furthermore, CSF or neuroimaging biomarkers were consistent with Alzheimer’s disease pathophysiology, although CSF p-tau was normal in 24% of cases. Fifteen of the executive predominate participants enrolled in research neuroimaging protocols and were compared to amnestic (n = 110), visual (n = 18) and language (n = 7) predominate clinical phenotypes of Alzheimer’s disease. This revealed a consistent pattern of hypometabolism in parieto-frontal brain regions supporting executive functions with relative sparing of the medial temporal lobe (versus amnestic phenotype), occipital (versus visual phenotype) and left temporal (versus language phenotype). We propose that this progressive dysexecutive syndrome should be recognized as a distinct clinical phenotype disambiguated from behavioural presentations and not linked specifically to the frontal lobe or a particular anatomic substrate without further study. This clinical presentation can be due to Alzheimer’s disease but is likely not specific for any single aetiology. Diagnostic criteria are proposed to facilitate additional research into this understudied clinical presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, episodic memory impairment is more prominent in Alzheimer's disease than in behavioural variant frontotemporal dementia, although a dysexecutive or behavioural Alzheimer's disease variant is recognised.5”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Dysexecuitve syndrome, which involves impairment of working memory, cognitive flexibility and inhibitory control, is seen in progressive dementia syndrome due to Alzheimer disease. This syndrome is accompanied by frontoparietal hypometabolism as demonstrated by positron emission tomography104.”
From Cognitive and behavioural flexibility: Neural mechanisms and clinical considerations (2021) · cites this paper as [104]
In the citing paper
“Thus, these biomarkers can be used to identify patients who have frontal lobe dysfunction on the basis of AD pathology, rather than FTD, a condition sometimes called frontal variant AD.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationStudies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“Thal amyloid phase was performed using Ab immunohistochemistry (Thal et al., 2002) and Braak tangle stage was performed using tau immunohistochemistry (Braak and Braak, 1991).”
MethodMiyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000) · Cognitive Psychology · doi:10.1006/cogp.1999.0734 · Cited by 15,798
Diamond, A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143750 · Cited by 13,268
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationValidity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
Ashburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507
Baddeley, A. (1992) · Science · doi:10.1126/science.1736359 · Cited by 5,258
Working memory: Looking back and looking forward
Baddeley, A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1201 · Cited by 5,200 · cited 2×
“This dysfunction is related to specific disruption of brain regions involved in executive functions (Baddeley, 2003) with relative sparing of brain regions supporting other functions (e.”
Background
Research works printed but not linked: 1
- Spreen, 1998, General intellectual ability and assessment of premorbid intelligence, A compendium of neuropsychological tests, 43
Cited by
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Self-citationFour distinct trajectories of tau deposition identified in Alzheimer’s disease
Initiative, T. A. D. N., Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01309-6 · Cited by 741
New insights into atypical Alzheimer's disease in the era of biomarkers
Graff-Radford, J., Yong, K. X. X., Apostolova, L. G., Bouwman, F. H., Carrillo, M., Dickerson, B. C., Rabinovici, G. D., Schott, J. M., Jones, D. T., & Murray, M. E. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30440-3 · Cited by 706
Self-citationCognitive and behavioural flexibility: Neural mechanisms and clinical considerations
Uddin, L. Q. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00428-w · Cited by 698
Donanemab: Appropriate use recommendations
Rabinovici, G. D., Selkoe, D. J., Schindler, S. E., Aisen, P., Apostolova, L. G., Atri, A., Greenberg, S. M., Hendrix, S. B., Petersen, R. C., Weiner, M., et al. (2025) · The Journal of Prevention of Alzheimer's Disease · doi:10.1016/j.tjpad.2025.100150 · Cited by 278
Self-citationExecutive Dysfunction and the Prefrontal Cortex
Jones, D. T., & Graff-Radford, J. (2021) · Continuum · doi:10.1212/con.0000000000001009 · Cited by 256
Self-citationBoeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00341-0 · Cited by 218
Self-citationRabinovici, G. D., Knopman, D. S., Arbizu, J., Benzinger, T. L. S., Donohoe, K. J., Hansson, O., Herscovitch, P., Kuo, P. H., Lingler, J. H., Minoshima, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14338 · Cited by 202
Self-citationBiomarker-based staging of Alzheimer disease: rationale and clinical applications
Therriault, J., Schindler, S. E., Salvadó, G., Pascoal, T. A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Apostolova, L., Murray, M. E., Verberk, I., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00942-2 · Cited by 197
Self-citationFrontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Self-citationRecent update on the heterogeneity of the Alzheimer’s disease spectrum
Jellinger, K. A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02449-2 · Cited by 169
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Sirkis, D. W., Bonham, L. W., Johnson, T. P., La Joie, R., & Yokoyama, J. S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01531-9 · Cited by 151
La Joie, R., Visani, A. V., Lesman-Segev, O. H., Baker, S. L., Edwards, L., Iaccarino, L., Soleimani-Meigooni, D. N., Mellinger, T., Janabi, M., Miller, Z. A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011270 · Cited by 130
Ossenkoppele, R., Singleton, E. H., Groot, C., Dijkstra, A. A., Eikelboom, W. S., Seeley, W. W., Miller, B. L., Laforce, R. J., Scheltens, P., Papma, J. M., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.4417 · Cited by 141
Schilling, L. P., Balthazar, M. L. F., Radanovic, M., Forlenza, O. V., Silagi, M. L., Smid, J., Barbosa, B. J. A. P., Frota, N. A. F., de Souza, L. C., Vale, F. A. C., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s102pt · Cited by 128
Predicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
“language, visuospatial, and dysexecutive) (Gorno-Tempini et al., 2011; Crutch et al., 2017; Townley et al., 2020).”
Self-citationVillain, N., Planche, V., Lilamand, M., Cordonnier, C., Soto‐Martin, M., Mollion, H., Bombois, S., & Delrieu, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100094 · Cited by 95
Cho, H., Mundada, N. S., Apostolova, L. G., Carrillo, M. C., Shankar, R. P., Amuiri, A. N., Zeltzer, E., Windon, C., Soleimani‐Meigooni, D. N., Tanner, J. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13453 · Cited by 88
Self-citationRabinovici, G. D., Knopman, D. S., Arbizu, J., Benzinger, T. L. S., Donohoe, K. J., Hansson, O., Herscovitch, P., Kuo, P. H., Lingler, J. H., Minoshima, S., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268756 · Cited by 90
Self-citationChapleau, M., Joie, R. L., Yong, K. X. X., Agosta, F., Allen, I. E., Apostolova, L. G., Best, J., Boon, B. D. C., Crutch, S. J., Filippi, M., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00414-3 · Cited by 82
Self-citationA computational model of neurodegeneration in Alzheimer’s disease
Jones, D., Lowe, V., Graff-Radford, J., Botha, H., Barnard, L., Wiepert, D., Murphy, M. C., Murray, M., Senjem, M., Gunter, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29047-4 · Cited by 78
Self-citationSchilling, L. P., Balthazar, M. L. F., Radanovic, M., Forlenza, O. V., Silagi, M. L., Smid, J., Barbosa, B. J. A. P., Frota, N. A. F., de Souza, L. C., Vale, F. A. C., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s102en · Cited by 65
McDade, E. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001131 · Cited by 63
Therriault, J., Pascoal, T. A., Savard, M., Benedet, A. L., Chamoun, M., Tissot, C., Lussier, F. Z., Kang, M. S., Thomas, E. M., Terada, T., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011081 · Cited by 59
Touroutoglou, A., Katsumi, Y., Brickhouse, M. J., Zaitsev, A., Eckbo, R., Aisen, P. S. S., Beckett, L. A., Dage, J. L., Eloyan, A., Foroud, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13466 · Cited by 53
Self-citationdel Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Breakdown of specific functional brain networks in clinical variants of Alzheimer’s disease
Pini, L., Wennberg, A. M. V., Salvalaggio, A., Vallesi, A., Pievani, M., & Corbetta, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101482 · Cited by 51
Falgàs, N., Allen, I. E., Spina, S., Grant, H. E., Piña‐Escudero, S. D., Merrilees, J. J., Gearhart, R., Rosen, H. J., Kramer, J. H., Seeley, W. W., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15203 · Cited by 44
Tisdall, M. D., Ohm, D. T., Lobrovich, R., Das, S. R., Mizsei, G., Prabhakaran, K., Ittyerah, R., Lim, S., McMillan, C. T., Wolk, D. A., et al. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102913 · Cited by 38
Tau and the fractionated default mode network in atypical Alzheimer’s disease
Putcha, D., Eckbo, R., Katsumi, Y., Dickerson, B. C., Touroutoglou, A., & Collins, J. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac055 · Cited by 42
Atypical Alzheimer Disease Variants
Polsinelli, A. J., & Apostolova, L. G. (2022) · Continuum · doi:10.1212/con.0000000000001082 · Cited by 39
Self-citationGroot, C., Grothe, M. J., Mukherjee, S., Jelistratova, I., Jansen, I. E., van Loenhoud, A. C., Risacher, S. L., Saykin, A. J., Donald, C. L. M., Mez, J., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102660 · Cited by 33
Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer’s disease
Putcha, D., Katsumi, Y., Brickhouse, M. J., Flaherty, R., Salat, D. H., Touroutoglou, A., & Dickerson, B. C. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103303 · Cited by 33
Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease
Katsumi, Y., Howe, I., Eckbo, R., Wong, B., Quimby, M., Hochberg, D., McGinnis, S. M., Putcha, D., Wolk, D. A., Touroutoglou, A., et al. (2024) · Brain · doi:10.1093/brain/awae327 · Cited by 32
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease
Singleton, E. H., Hansson, O., Pijnenburg, Y. A. L., Joie, R. L., Mantyh, W. G., Tideman, P., Stomrud, E., Leuzy, A., Johansson, M., Strandberg, O. T., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325497 · Cited by 32
Self-citationMonoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 32
Arezoumandan, S., Xie, S. X., Cousins, K. A. Q., Mechanic-Hamilton, D. J., Peterson, C. S., Huang, C. Y., Ohm, D. T., Ittyerah, R., McMillan, C. T., Wolk, D. A., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02472-x · Cited by 31
PET Imaging of Dementia: Update 2022
Burkett, B. J., Babcock, J. C., Lowe, V. J., Graff‐Radford, J., Subramaniam, R. M., & Johnson, D. R. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004251 · Cited by 30
Self-citationMapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia
Ramanan, S., El-Omar, H., Roquet, D., Ahmed, R. M., Hodges, J. R., Piguet, O., Ralph, M. A. L., & Irish, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac344 · Cited by 30
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease
Kouri, N., Frankenhauser, I., Peng, Z., Labuzan, S. A., Boon, B. D. C., Moloney, C. M., Pottier, C. P., Wickland, D. P., Caetano-Anollés, K., Corriveau‐Lecavalier, N., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.0784 · Cited by 28
Self-citationKeith, C. M., Haut, M. W., Wilhelmsen, K. C., Mehta, R. I., Miller, M. D., Navia, R. O., Ward, M., Lindberg, K. E., Coleman, M., McCuddy, W. T., et al. (2022) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2022.2144618 · Cited by 27
Frank, B. E., Ally, M., Tripodis, Y., Puzo, C. J., Labriola, C., Hurley, L., Martin, B. M., Palmisano, J. N., Chan, L., Steinberg, E. G., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200304 · Cited by 26
Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET
Townley, R. A., Botha, H., Graff‐Radford, J., Whitwell, J. L., Boeve, B. F., Machulda, M. M., Fields, J. A., Drubach, D. A., Savica, R., Petersen, R. C., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab182 · Cited by 26
Self-citationBarnard, L., Botha, H., Corriveau-Lecavalier, N., Graff-Radford, J., Dicks, E., Gogineni, V., Zhang, G., Burkett, B. J., Johnson, D. R., Huls, S. J., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213831 · Cited by 25
Self-citationAge-at-Onset and APOE -Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease
Smirnov, D. S., Galasko, D., Hiniker, A., Edland, S. D., & Salmon, D. P. (2021) · Neurology · doi:10.1212/wnl.0000000000011772 · Cited by 25
Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer’s disease
Corriveau‐Lecavalier, N., Barnard, L. R., Lee, J., Dicks, E., Botha, H., Graff‐Radford, J., Machulda, M. M., Boeve, B. F., Knopman, D. S., Lowe, V. J., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad017 · Cited by 26
Self-citationCorriveau‐Lecavalier, N., Gunter, J. L., Kamykowski, M. G., Dicks, E., Botha, H., Kremers, W. K., Graff‐Radford, J., Wiepert, D. A., Schwarz, C. G., Yacoub, E. S., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad058 · Cited by 25
Self-citationAn ensemble learning model for continuous cognition assessment based on resting-state EEG
Sun, J., Sun, Y., Shen, A., Li, Y., Gao, X., & Lu, B. (2024) · npj Aging · doi:10.1038/s41514-023-00129-x · Cited by 25
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis
Ramanan, V. K., Gebre, R. K., Graff-Radford, J., Hofrenning, E., Algeciras-Schimnich, A., Figdore, D. J., Lowe, V. J., Mielke, M. M., Knopman, D. S., Ross, O. A., et al. (2023) · Brain · doi:10.1093/brain/awad196 · Cited by 24
Self-citationDifferential trajectories of hypometabolism across cognitively-defined Alzheimer’s disease subgroups
Groot, C., Risacher, S. L., Chen, J. Q. A., Dicks, E., Saykin, A. J., Donald, C. L. M., Mez, J., Trittschuh, E. H., Mukherjee, S., Barkhof, F., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102725 · Cited by 24
Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease
Singleton, E. H., Pijnenburg, Y. A. L., Sudre, C. H., Groot, C., Kochova, E., Barkhof, F., Joie, R. L., Rosen, H. J., Seeley, W. W., Miller, B. L., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00717-z · Cited by 24
Putcha, D., Katsumi, Y., Touroutoglou, A., Eloyan, A., Taurone, A., Thangarajah, M., Aisen, P. S. S., Dage, J. L., Foroud, T., Jack, C. R., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01689-8 · Cited by 23
Self-citationA systematic review of atypical Alzheimer's disease including behavioural and psychological symptoms
Shea, Y. F., Pan, Y., Mak, H. K., Bao, Y., Lee, S., Chiu, P. K., & Chan, H. W. F. (2021) · Psychogeriatrics · doi:10.1111/psyg.12665 · Cited by 22
Behavioral Variant Frontotemporal Dementia
Boeve, B. F. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001105 · Cited by 21
Self-citationAtypical Presentations of Alzheimer Disease
Jones, D. T., Pelak, V. S., & Rogalski, E. J. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001504 · Cited by 19
Self-citationWhitwell, J. L., Martin, P. R., Graff-Radford, J., Machulda, M. M., Sintini, I., Buciuc, M., Senjem, M. L., Schwarz, C. G., Botha, H., Carrasquillo, M. M., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200336 · Cited by 19
Self-citationBenussi, A., Agosta, F., Alfano, A. R., Antico, A., Bellelli, G., Bonanni, L., Bottini, G., Bozzali, M., Brignoli, O., Bruno, G., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08576-y · Cited by 18
Quispialaya, K. M., Therriault, J., Aliaga, A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Macedo, A. C., Rahmouni, N., Tissot, C., Arias, J. F., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000210211 · Cited by 19
Atypical clinical variants of Alzheimer’s disease: are they really atypical?
Whitwell, J. L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1352822 · Cited by 17
Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
Doher, N., Davoudi, V., Magaki, S., Townley, R. A., Haeri, M., & Vinters, H. V. (2023) · Neurology International · doi:10.3390/neurolint15030054 · Cited by 16
Self-citationChen, Y., Li, Z., Ge, X., Lv, H., & Geng, Z. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1359631 · Cited by 16
My works are correct, B. M. I. A. A. I. S. R. L. M. T. I. D. A.-M., Delgado, M. G., Amado-Fuentes, M., Carlos‐Vivas, J., & Gómez, A. G. (2021) · Children · doi:10.3390/children8090799 · Cited by 16
Corriveau‐Lecavalier, N., Machulda, M. M., Botha, H., Graff‐Radford, J., Knopman, D. S., Lowe, V. J., Fields, J. A., Stricker, N. H., Boeve, B. F., Jack, C. R., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11025-x · Cited by 16
Self-citationRibas, M. Z., Paticcié, G. F., Noleto, F. M., Ramanzini, L. G., Veras, A. D. O., DALL'OGLIO, R., Filho, L. B. D. A., da Silva, J. G. M., Lima, M. P. P., Teixeira, B. E., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101866 · Cited by 16
Basaglia-Pappas, S., Laurent, B., Getenet, J., Boulangé, A., Cruz, A. R. D. L., Loureiro, I. S., & Lefèbvre, L. (2023) · Brain Sciences · doi:10.3390/brainsci13030406 · Cited by 16
Frontal variant Alzheimer's disease: A systematic narrative synthesis
Brown, A., Salo, S. K., & Savage, G. R. (2023) · Cortex · doi:10.1016/j.cortex.2023.05.007 · Cited by 16
Longitudinal Evolution of Posterior Cortical Atrophy
Shir, D., Lee, N. A., McCarter, S. J., Ramanan, V. K., Botha, H., Knopman, D. S., Petersen, R. C., Boeve, B. F., Day, G. S., Graff‐Radford, N. R., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213559 · Cited by 14
Self-citationEvaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging
Loreto, F., Gunning, S., Golemme, M., Watt, H., Patel, N., Win, Z., Carswell, C. J., Perry, R. J., & Malhotra, P. (2021) · Brain Communications · doi:10.1093/braincomms/fcab035 · Cited by 13
Comorbid neuropathology and atypical presentation of Alzheimer's disease
Piña‐Escudero, S. D., Joie, R. L., Spina, S., Hwang, J., Miller, Z., Huang, E. J., Grant, H. E., Mundada, N. S., Boxer, A. L., Gorno‐Tempini, M., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12602 · Cited by 12
Reijner, N., Frigerio, I., Bouwman, M. M. A., Boon, B. D. C., Guizard, N., Jubault, T., Hoozemans, J. J. M., Rozemüller, A. J. M., Bouwman, F. H., Barkhof, F., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01727-5 · Cited by 11
Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases
Corriveau‐Lecavalier, N., Barnard, L. R., Botha, H., Graff‐Radford, J., Ramanan, V. K., Lee, J., Dicks, E., Rademakers, R., Boeve, B. F., Machulda, M. M., et al. (2023) · Brain · doi:10.1093/brain/awad356 · Cited by 11
Self-citationArber, C., Belder, C. R. S., Tomczuk, F., Gabriele, R. M. C., Buhidma, Y., Farrell, C., O’Connor, A., Rice, H., Lashley, T., Fox, N. C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13904 · Cited by 11
Three cases of Creutzfeldt–Jakob disease presenting with a predominant dysexecutive syndrome
Corriveau‐Lecavalier, N., Li, W., Ramanan, V. K., Drubach, D. A., Day, G. S., & Jones, D. T. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11045-7 · Cited by 11
Self-citationAtypical forms of Alzheimer's disease: patients not to forget
Montembeault, M., & Migliaccio, R. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001182 · Cited by 11
Corriveau‐Lecavalier, N., Alden, E., Stricker, N. H., Machulda, M. M., & Jones, D. T. (2022) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acac016 · Cited by 10
Self-citationKeith, C. M., Haut, M. W., D’Haese, P.-F., Mehta, R. I., Teixeira, C. V. L., Coleman, M. M., Miller, M. D., Ward, M., Navia, R. O., Marano, G., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230049 · Cited by 10
Leffa, D. T., Povala, G., Bellaver, B., Ferrari‐Souza, J. P., Ferreira, P. C. L., Lussier, F. Z., Aguzzoli, C. S., Soares, C., Zalzale, H., Rohden, F., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70003 · Cited by 10
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease
Ramanan, V. K., Heckman, M. G., Lesnick, T. G., Przybelski, S. A., Cahn, E. J., Kosel, M., Murray, M. E., Mielke, M. M., Botha, H., Graff‐Radford, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02419-2 · Cited by 10
Self-citationButts, A. M., Machulda, M. M., Martin, P. R., Przybelski, S. A., Duffy, J. R., Graff‐Radford, J., Knopman, D. S., Petersen, R. C., Jack, C. R., Lowe, V. J., et al. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220010 · Cited by 10
Self-citationExploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes
Elman, J. A., Schork, N. J., Rangan, A. V., & Initiative, F. T. A. D. N. (2024) · Journal of Alzheimer’s Disease · doi:10.3233/jad-231252 · Cited by 9
The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes
Boccalini, C., Caminiti, S. P., Chiti, A., Frisoni, G. B., Garibotto, V., Perani, D., & Initiative, T. A. D. N. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52039 · Cited by 9
Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer’s Disease
Herholz, K. (2022) · Brain Sciences · doi:10.3390/brainsci12020146 · Cited by 9
Auditory naming is impaired in posterior cortical atrophy and early-onset Alzheimer’s disease
Putcha, D., Eustace, A., Carvalho, N., Wong, B., Quimby, M., & Dickerson, B. C. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1342928 · Cited by 9
Nabizadeh, F., Pirahesh, K., Aarabi, M. H., Wennberg, A. M. V., & Pini, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29420 · Cited by 9
Default mode network failure across the Alzheimer’s disease spectrum
Corriveau‐Lecavalier, N., Dicks, E., Martin, P. R., Wiste, H. J., Gunter, J. L., Kamykowski, M. G., Senjem, M. L., Schwarz, C. G., Botha, H., Graff‐Radford, J., et al. (2026) · Brain · doi:10.1093/brain/awag146 · Cited by 8
Self-citationAlzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology
Boon, B. D. C., Frigerio, I., de Gooijer, D., Morrema, T. H. J., Bol, J. G. J. M., Galis, Y., Heymans, M. W., Bank, N. B., Murray, M. E., Amsterdam, N. A. B. C., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.13009 · Cited by 8
Self-citationPreclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Establishing an Alzheimer Disease Therapeutics Clinic: Experience From a Year of Evaluations
Neth, B. J., Graff‐Radford, J., Cogswell, P. M., Johnson, D. R., Botha, H., McCarter, S. J., Jones, D. T., Conkins, M. M., Hardin, D., Spence, J. J., et al. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.09.019 · Cited by 7
Self-citationLeite, J., Gonçalves, Ó. F., & Carvalho, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.880510 · Cited by 7
Malotaux, V., Colmant, L., Quenon, L., Huyghe, L., Gérard, T., Dricot, L., Ivanoiu, A., Lhommel, R., & Hanseeuw, B. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230696 · Cited by 7
Fredes-Roa, C., Gutiérrez-Barría, F., Ramírez-Bruna, C., Cigarroa, I., Martella, D., Julio–Ramos, T., Méndez‐Orellana, C., & Toloza–Ramirez, D. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.07.007 · Cited by 7
Rethinking the diagnosis of primary progressive aphasia: current challenges and future directions
Macoir, J., Lavoie, M., Duboisdindien, G., & Laforce, R. J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1736855 · Cited by 6
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 6
Multiple aetiologies of the progressive dysexecutive syndrome and the importance of biomarkers
Jones, D. T. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa127 · Cited by 6
Self-citationSpatial orientation – a stable marker for vascular cognitive impairment?
Lowry, E., Coughlan, G., Morrissey, S., Jeffs, S., & Hornberger, M. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100155 · Cited by 6
Social cognition and behavioral changes in patients with posterior cortical atrophy
St-Georges, M.-A., Wang, L., Chapleau, M., Migliaccio, R., Carrier, T., & Montembeault, M. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12089-z · Cited by 5
Aβ 42/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease
Singh, N. A., Graff‐Radford, J., Li, D., Mielke, M. M., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Jack, C. R., Lowe, V. J., Josephs, K. A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251333450 · Cited by 4
Self-citationSreepada, L. P., Brown, C. A., Das, S. R., Yushkevich, P. A., Wolk, D. A., & McMillan, C. T. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.06.003 · Cited by 4
Ramanan, V. K., Heckman, M. G., Hofrenning, E. I., Przybelski, S. A., Graff‐Radford, J., Lowe, V. J., Machulda, M. M., Murray, M. E., Algeciras‐Schimnich, A., Figdore, D. J., et al. (2025) · Neurology Genetics · doi:10.1212/nxg.0000000000200266 · Cited by 4
Self-citationHorne, K., Chen, T., & Irish, M. (2024) · British Journal of Clinical Psychology · doi:10.1111/bjc.12505 · Cited by 4
Metadata
- Authors
- Townley, R. A., Graff-Radford, J., Mantyh, W. G., Botha, H., Polsinelli, A. J., Przybelski, S. A., Machulda, M. M., Makhlouf, A. T., Senjem, M. L., Murray, M. E., Reichard, R. R., Savica, R., Boeve, B. F., Drubach, D. A., Josephs, K. A., Knopman, D. S., Lowe, V. J., Jack, C. R., Petersen, R. C., & Jones, D. T.
- Affiliations
- Mayo Clinic (US)
- Department of Neurology Mayo Clinic, Rochester, MN 55902, USA
- Mayo Clinic in Florida (US)
- Corresponding author
- Jones, David T
- ORCID
- Venue
- Brain Communications
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-01-01
- Volume
- 2
- Issue
- 1
- Pages
- fcaa068-fcaa068
- ISSN
- 2632-1297 (ISSN-L)
- PMC
- PMC7325839
- OpenAlex
- W3031694559
- Cited by
- 145
- References
- 86
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 23 · 2023: 19 · 2022: 27 · 2021: 18 · 2020: 19
- FWCI
- 15.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Brain Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- AVID Radiopharmaceuticals, Inc
- NIH
- National Institutes of Health (P50 AG016574, U01 AG006786, R37 AG11378, R01 AG054449, R01 AG041851, R01 AG011378, R01 AG034676, R01 AG37491, R01 NS097495)
- Robert Wood Johnson Foundation
- Elsie and Marvin Dekelboum Family Foundation
- Liston Family Foundation
- Gerald and Henrietta Rauenhorst Foundation
- Foundation Dr. Corinne Schuler
- Alexander Family Alzheimer’s Disease Research
- Mayo Clinic, and the Mayo Foundation for Medical Education and Research
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
- Keywords
- Alzheimer's disease, executive dysfunction, early-onset Alzheimer's disease, clinical phenotype, FDG-PET hypometabolism, APOE ε4, cerebrospinal fluid biomarkers, EEG slowing, working memory, cognitive flexibility, inhibitory control, differential diagnosis of dementia, clinical criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.